Blisson Mediplus Private Limited - Due diligence report

A 360° intelligence report on Blisson Mediplus Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2013-06-10 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
BM Blisson Mediplus Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Blisson Mediplus Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Blisson Mediplus Private Limited is assessed as Low Risk with a Trust Score of 81/100. Blisson Mediplus Private Limited is an active private limited indian non-government company incorporated in 2013, operating in the Healthcare sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Blisson Mediplus Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 3 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUBHENDU CHATTOPADHYAY 01234567 Director 01/04/2018 6 yrs Approved
TUSHAR MADHUKAR PATIL 01234567 Director 01/04/2018 6 yrs Approved
MEHUL PRAVIN SHAH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 70
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 13+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
09 May 2022
Securities allotted
250000 Debentures - 2.50 cr raised
16 Nov 2021
Securities allotted
40000 Equity Shares - 4.00 Lakh raised
31 Dec 2020
Director ceased
SUBHENDU CHATTOPADHYAY
Director ceased
TUSHAR MADHUKAR PATIL
28 Dec 2020
Director ceased
RAVIRAJ MUDDANNA SHETTY
16 Dec 2019
Director appointed
SUBHENDU CHATTOPADHYAY (Director)
Director appointed
TUSHAR MADHUKAR PATIL (Director)
10 Oct 2019
Director ceased
PRAVIN VRAJLAL SHAH
31 Mar 2016
Share transfer (FY 2016)
5000.00000000 shares to VRAJLAL SHAH
01 Dec 2014
Director ceased
REJITHA CHANDRAN
10 Jun 2013
Incorporated
Registered with Roc Mumbai I
Director appointed
MEHUL PRAVIN SHAH (Director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Triomics U85300UP2020PTC136648 Surajpur, Uttar Pradesh, India
Progenesis Ivf Private Limited U85320MH2019PTC330820 Thane, Maharashtra, India
Polo Labs U70200CH1998PTC021322 Chandigarh, Chandigarh, India
Igenetic Diagnostics U33111DL2013PTC458568 New Delhi, Delhi, India
Sakhiyaskinclinic U85110GJ2011PLC121885 Surat City, Gujarat, India
Gemini Scans Private Limited U33125TN2006PTC061121 Chennai, Tamil Nadu, India
Mp Biomedicals India Private Limited U24100MH2009PTC191394 Navi Mumbai, Maharashtra, India
Bhoomika Healthcare Limited U85110OR2020PLC034530 Bhubaneswar, Orissa, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Blisson Mediplus Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Blisson Mediplus Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Blisson Mediplus Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Blisson Mediplus Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Blisson Mediplus Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Blisson Mediplus Private Limited an active company?

Blisson Mediplus Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Blisson Mediplus Private Limited financially healthy?

Blisson Mediplus Private Limited has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Blisson Mediplus Private Limited?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Blisson Mediplus Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Blisson Mediplus Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Blisson Mediplus Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Blisson Mediplus Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.